Provided is a pharmaceutical composition comprising a human antibody, or antigen binding portion thereof, capable of binding to an epitope of the p40 subunit of IL-12, and at least one additional agent selected from the group consisting of a buffer, a polyalcohol and a surfactant. The antibody can be used to treat various inflammatory diseases, including arthritis, colitis, asthma and psoriasis.